Jade Biosciences, Inc. · NASDAQ:JBIO
BlackRock, Inc. reported a 6.60% stake in Jade Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 6.60% stake in Jade Biosciences, Inc., 2,150,203 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 6.60%
- Shares
- 2,150,203
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.60% | 2,150,203 |
Source
Related
- Jade Biosciences, Inc.
- BlackRock, Inc.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026